Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANVS compared with ECX: revenue, margins and what each company keeps, and the suppliers and customers both name
ANVS
Annovis Bio, Inc.
Change
Mkt cap
Revenue
Revenue
ECX
ECARX Holdings Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANVS
Annovis Bio, Inc.
vs
ECX
ECARX Holdings Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
ANVS
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±37.6%
▼
−5.95%
×0.16
ECX
1 of 4 reports
Report
implied
realized
× implied
Aug 11 '26
—
▼
−0.95%
—
= implied
ANVS realized, solid
ECX realized, hatched
One scale, both sides: full bar = 38%
× = |realized| ÷ implied
Source: market data
ANVS
Annovis Bio, Inc.
Change
1.14
▲
+11.86%
· post 1.13
Mkt cap
$48.1M
ECX
ECARX Holdings Inc.
Change
0.89
▲
+11.20%
· post 0.89
Closed
Oct 30 '26
Mkt cap
$319.0M
vs
Compare
Closed
Oct 30 '26
ANVS
Annovis Bio, Inc.
vs
ECX
ECARX Holdings Inc.
1.14
▲
+11.86%
post 1.13
Price
0.89
▲
+11.20%
post 0.89
$48.1M
Mkt cap
$319.0M
Change
Change
ANVS
1.14
▲
+11.86%
vs
ECX
0.89
▲
+11.20%
Closed
Oct 30 '26